These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32293344)

  • 1. Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.
    Huang B; Wang J; Sun M; Chen X; Xu D; Li ZP; Ma J; Feng ST; Gao Z
    BMC Cancer; 2020 Apr; 20(1):322. PubMed ID: 32293344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
    Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
    Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.
    Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
    NMR Biomed; 2021 Feb; 34(2):e4426. PubMed ID: 33078438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy.
    Teo KY; Daescu O; Cederberg K; Sengupta A; Leavey PJ
    PLoS One; 2022; 17(2):e0259564. PubMed ID: 35157711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive intravoxel incoherent motion MRI in prediction of histopathological response to neoadjuvant chemotherapy and survival outcome in osteosarcoma at the time of diagnosis.
    Baidya Kayal E; Bakhshi S; Kandasamy D; Sharma MC; Khan SA; Kumar VS; Khare K; Sharma R; Mehndiratta A
    J Transl Med; 2022 Dec; 20(1):625. PubMed ID: 36575510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
    Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
    Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLIC-supervoxels-based response evaluation of osteosarcoma treated with neoadjuvant chemotherapy using multi-parametric MR imaging.
    Baidya Kayal E; Kandasamy D; Sharma R; Sharma MC; Bakhshi S; Mehndiratta A
    Eur Radiol; 2020 Jun; 30(6):3125-3136. PubMed ID: 32086578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.
    Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
    Eur J Radiol; 2019 Oct; 119():108635. PubMed ID: 31445487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.
    Uhl M; Saueressig U; Koehler G; Kontny U; Niemeyer C; Reichardt W; Ilyasof K; Bley T; Langer M
    Pediatr Radiol; 2006 Dec; 36(12):1306-11. PubMed ID: 17031633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis.
    Bajpai J; Kumar R; Sreenivas V; Sharma MC; Khan SA; Rastogi S; Malhotra A; Gamnagatti S; Kumar R; Safaya R; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):e271-8. PubMed ID: 22193290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.
    Wang CS; Du LJ; Si MJ; Yin QH; Chen L; Shu M; Yuan F; Fei XC; Ding XY
    PLoS One; 2013; 8(8):e72679. PubMed ID: 23991141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1 mapping as a surrogate marker of chemotherapy response evaluation in patients with osteosarcoma.
    Baidya Kayal E; Sharma N; Sharma R; Bakhshi S; Kandasamy D; Mehndiratta A
    Eur J Radiol; 2022 Mar; 148():110170. PubMed ID: 35086004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging for neoadjuvant chemotherapy response evaluation in patients with osteosarcoma.
    Yin P; Xu J; Sun X; Liu T; Chen L; Hong N
    Eur J Radiol; 2023 May; 162():110790. PubMed ID: 36963332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI for evaluation of preoperative chemotherapy in osteosarcoma.
    Yildirim O; Al Khatalin M; Kargin OA; Camurdan VB
    Radiography (Lond); 2022 Aug; 28(3):593-604. PubMed ID: 35537246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prediction of chemotherapy response in primary osteosarcoma using the machine learning technique on radiomic data].
    Dufau J; Bouhamama A; Leporq B; Malaureille L; Beuf O; Gouin F; Pilleul F; Marec-Berard P
    Bull Cancer; 2019 Nov; 106(11):983-999. PubMed ID: 31587802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis.
    Bajpai J; Gamnagatti S; Kumar R; Sreenivas V; Sharma MC; Khan SA; Rastogi S; Malhotra A; Safaya R; Bakhshi S
    Pediatr Radiol; 2011 Apr; 41(4):441-50. PubMed ID: 20978754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update.
    Habre C; Dabadie A; Loundou AD; Banos JB; Desvignes C; Pico H; Aschero A; Colavolpe N; Seiler C; Bouvier C; Peltier E; Gentet JC; Baunin C; Auquier P; Petit P
    Pediatr Radiol; 2021 Aug; 51(9):1714-1723. PubMed ID: 33877417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.